Brief: Newbury Pharmaceuticals Secures Approval For Macitentan Film-Coated Tablets In Denmark
March 14 (Reuters) - Newbury Pharmaceuticals AB NEWBRY.ST: SECURES APPROVAL FOR MACITENTAN FILM-COATED TABLETS MARKETING AUTHORIZATION OF MACITENTAN NEWBURY IN DENMARK APPROVALS IN SWEDEN AND NORWAY ARE EXPECTED TO FOLLOW UPON THE COMPLETION OF NATIONAL REVIEWS Source text: ID:nMFN7MBltj Further company coverage: NEWBRY.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Newbury Pharmaceuticals AB
See all newsBrief: Newbury Secures Hospital Portfolio Rights In Iraq
Brief: Newbury Signs Licence And Supply Deal For Guanfacine
Brief: Newbury Pharmaceuticals Gets Approval for Tofacitinib Newbury
Brief: Newbury Pharmaceuticals Secures Generic Approval For Dalbavancin Newbury
Brief: Newbury Pharmaceuticals Reports Q3 EBITDA Of SEK -4 Mln